Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Zhengye Biotechnology Holding (ZYBT) Receivables - Net (2023 - 2025)

Zhengye Biotechnology Holding has reported Receivables - Net over the past 3 years, most recently at $2.6 million for Q4 2025.

  • Quarterly Receivables - Net fell 75.51% to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, down 75.51% year-over-year, with the annual reading at $5.2 million for FY2025, 50.13% down from the prior year.
  • Receivables - Net was $2.6 million for Q4 2025 at Zhengye Biotechnology Holding, down from $5.2 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $10.6 million in Q4 2024 and troughed at $2.6 million in Q4 2025.
  • The 3-year median for Receivables - Net is $7.7 million (2023), against an average of $7.2 million.
  • Year-over-year, Receivables - Net grew 3.31% in 2024 and then tumbled 75.51% in 2025.
  • A 3-year view of Receivables - Net shows it stood at $10.3 million in 2023, then rose by 3.31% to $10.6 million in 2024, then tumbled by 75.51% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Receivables - Net are $2.6 million (Q4 2025), $5.2 million (Q2 2025), and $10.6 million (Q4 2024).